文献速递妇科

电子自我评估与照护(eSAC)项目在晚期卵巢癌中的可用性与可接受性:一项混合方法研究

Usability and acceptability of the electronic self-assessment and care (eSAC) program in advanced ovarian cancer: A mixed methods study.
PubMed 文献 · Gynecol Oncol · 2022-09-21

本研究在单一门诊点招募晚期卵巢癌患者,通过邮件提示在每次就诊前填写症状/生活质量条目,以可接受性电子量表(AES)评分和半结构化访谈评估患者可接受性与可用性,同时用问卷和访谈评估临床医生。163例符合条件患者中143例(87.7%)签署知情同意;至少3次就诊前创建eSAC报告的患者(n=71)平均AES评分为26.19±3.36(满分30),访谈患者(n=33)认为eSAC易于使用且对就诊对话重要;临床医生问卷(n=8)和焦点小组(n=3)数据显示eSAC可接受且有用;混合方法分析显示定量与定性结果无重大差异,定性数据拓宽了对定量评分的理解。结论认为eSAC在该场景中有用且可接受,是加强晚期卵巢癌以患者为中心照护的有前景策略。

要点

  • 至少3次就诊前创建eSAC报告的患者(n=71)平均AES评分为26.19±3.36(满分30),评为可接受。
  • 访谈患者(n=33)认为eSAC易于使用且对就诊对话重要。
  • 临床医生问卷(n=8)和焦点小组(n=3)数据显示eSAC可接受且有用。

核心结论

  • eSAC在该场景中有用且可接受,是加强晚期卵巢癌以患者为中心照护的有前景策略。

研究设计与样本

  • 混合方法研究,患者参与者从单一门诊点招募,通过邮件提示在每次就诊前回答症状/生活质量条目。
  • 患者可接受性用可接受性电子量表评分(AES)测量,可用性在部分患者参与者中通过半结构化访谈测量。
  • 临床医生可接受性和可用性通过问卷和半结构化访谈测量;定量数据用描述性统计,定性数据用主题内容分析,并进行混合方法分析。

主要发现

  • 163例符合条件患者中143例(87.7%)提供书面知情同意。
  • 至少3次就诊前创建eSAC报告的患者参与者(n=71)平均AES评分为26.19±3.36(满分30)。
  • 患者参与者访谈数据(n=33)显示eSAC易于使用且对就诊对话重要。
  • 临床医生问卷(n=8)和焦点小组(n=3)数据显示eSAC项目对临床医生可接受且有用。
  • 定性分析提示患者和临床医生提出流程改进建议以提升在晚期卵巢癌场景中的有效性;混合方法分析显示定量与定性结果无重大差异,定性数据拓宽了对定量评分的理解。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine usability and acceptability of the electronic self-assessment and care (eSAC) web-based, patient reported outcome (PRO) program for people with advanced ovarian cancer. METHODS: Patient participants recruited from a single ambulatory site were prompted by email to answer symptom/quality of life items prior to each clinic visit. Patient participant acceptability was measured with the Acceptability E-Scale Score (AES). Usability was measured among a subset of patient participants using semi-structured interviews. Clinician participant acceptability and usability were measured via survey and semi-structured interviews. Quantitative data were analyzed with descriptive statistics. Qualitative data were analyzed using thematic content analysis. A mixed methods analysis was performed. RESULTS: Of 163 eligible patients approached, 143 (87.7%) provided written consent. Patient participants (n = 71) who created an eSAC report prior to at least 3 clinic visits, rated eSAC as acceptable with a mean AES score of 26.19 ± 3.36 (out of 30). Interview data from patient participants (n = 33) revealed that eSAC was easy to use and important to the clinic visit conversation. Data from clinician surveys (n = 8) and focus groups (n = 3) revealed that the eSAC program was acceptable and useful for clinicians. Qualitative analysis suggested process improvements from patients and clinicians for effectiveness in the advanced ovarian cancer setting. Mixed methods analysis demonstrated no major discrepancies between quantitative and qualitative findings, with the qualitative data broadening understanding of quantitative ratings. CONCLUSION: eSAC was useful and acceptable in this setting. This PRO is a promising strategy for enhancing patient-centered care for people with advanced ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wickline M, Wolpin S, Cho S, et al. Usability and acceptability of the electronic self-assessment and care (eSAC) program in advanced ovarian cancer: A mixed methods study. Gynecol Oncol. 2022. PMID: 36150917. doi:10.1016/j.ygyno.2022.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。